Spire Corporation to Develop Cryogenic Red Diode Lasers Funded by the MDA

Spire Corporation today announced that it has received a two-year, $998,514 Phase II Small Business Innovative Research (SBIR) contract from the Missile Defense Agency (MDA) to develop highly reliable, high power cryogenic red diode lasers.

The technology used to fabricate diode lasers is similar to that used by Spire to manufacture concentrator solar cells for terrestrial solar concentrator systems. When light shines on a concentrator cell it produces electricity whereas when an electrical current is applied to a diode laser it produces light. Both types of devices are fabricated from gallium arsenide wafers produced by metal organic chemical vapor deposition (MOCVD).

Bandwidth Semiconductor, Spire¡¦s wholly owned subsidiary, will carry out technical tasks related to epitaxial material growth and device processing. Using a state-of-the-art foundry, Bandwidth Semiconductor manufactures solar cells, as well as custom light emitting diodes and diode lasers for a broad range of applications.

Mr. Roger Little, CEO and Chairman of Spire Corporation, said, ¡§High power diode laser array technology is of interest to Spire because of its importance to this nation¡¦s defense. It also complements our solar cell product line. Bandwidth Semiconductor can efficiently produce these products.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.